|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roupret M, Babjuk M, Comperat E, Zigeuner
R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG,
Mostafid AH, et al: European association of urology guidelines on
upper urinary tract urothelial carcinoma: 2017 Update. Eur Urol.
73:111–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burger M, Grossman HB, Droller M,
Schmidbauer J, Hermann G, Drăgoescu O, Ray E, Fradet Y, Karl A,
Burgués JP, et al: Photodynamic diagnosis of non-muscle-invasive
bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis
of detection and recurrence based on raw data. Eur Urol.
64:846–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia
M, Zhan Y, Lin J, Chen Z, He A, et al: Tetracycline-inducible shRNA
targeting antisense long non-coding RNA HIF1A-AS2 represses the
malignant phenotypes of bladder cancer. Cancer Lett. 376:155–164.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang W, Liu T, Li T and Zhao X:
Hsa_circRNA_102002 facilitates metastasis of papillary thyroid
cancer through regulating miR-488-3p/HAS2 axis. Cancer Gene Ther.
28:229–293. 2021. View Article : Google Scholar
|
|
9
|
Jia YJ, Liu M and Wang S: CircRNA
hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis
in endometrial cancer via downregulating LRIG2 by sponging miR-182.
Cancer Cell Int. 20:4122020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun Z, Niu S, Xu F, Zhao W, Ma R and Chen
M: CircAMOTL1 promotes tumorigenesis through miR-526b/SIK2 axis in
cervical cancer. Front Cell Dev Biol. 8:5681902020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan D, Dong W, He Q, Yang M, Huang L, Kong
J, Qin H, Lin T and Huang J: Circular RNA circPICALM sponges
miR-1265 to inhibit bladder cancer metastasis and influence FAK
phosphorylation. EBioMedicine. 48:316–331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen B, Wei W, Huang X and Xie X, Kong Y,
Dai D, Yang L, Wang J, Tang H and Xie X: circEPSTI1 as a prognostic
marker and mediator of triple-negative breast cancer progression.
Theranostics. 8:4003–4015. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang G, Wang X, Liu B, Lu Z, Xu Z, Xiu P,
Liu Z and Li J: circ-BIRC6, a circular RNA, promotes hepatocellular
carcinoma progression by targeting the miR-3918/Bcl2 axis. Cell
Cycle. 18:976–989. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luk IS, Shrestha R, Xue H, Wang Y, Zhang
F, Lin D, Haegert A, Wu R, Dong X, Collins CC, et al: BIRC6
targeting as potential therapy for advanced, enzalutamide-resistant
prostate cancer. Clin Cancer Res. 23:1542–1551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang W, Xue R, Weng S, Wu J, Fang Y, Wang
Y, Ji L, Hu T, Liu T, Huang X, et al: BIRC6 promotes hepatocellular
carcinogenesis: Interaction of BIRC6 with p53 facilitating p53
degradation. Int J Cancer. 136:E475–E487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luk SU, Xue H, Cheng H, Lin D, Gout PW,
Fazli L, Collins CC, Gleave ME and Wang Y: The BIRC6 gene as a
novel target for therapy of prostate cancer: Dual targeting of
inhibitors of apoptosis. Oncotarget. 5:6896–6908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong X, Lin D, Low C, Vucic EA, English
JC, Yee J, Murray N, Lam WL, Ling V, Lam S, et al: Elevated
expression of BIRC6 protein in non-small-cell lung cancers is
associated with cancer recurrence and chemoresistance. J Thorac
Oncol. 8:161–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He Q, Zhao L, Liu Y, Liu X, Zheng J, Yu H,
Cai H, Ma J, Liu L, Wang P, et al: circ-SHKBP1 regulates the
angiogenesis of U87 glioma-exposed endothelial cells through
miR-544a/FOXP1 and miR-379/FOXP2 pathways. Mol Ther Nucleic Acids.
10:331–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Liu H, Hou L, Wang G, Zhang R,
Huang Y, Chen X and Zhu J: Circular RNA_LARP4 inhibits cell
proliferation and invasion of gastric cancer by sponging miR-424-5p
and regulating LATS1 expression. Mol Cancer. 16:1512017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bi J, Liu H, Dong W, Xie W, He Q, Cai Z,
Huang J and Lin T: Circular RNA circ-ZKSCAN1 inhibits bladder
cancer progression through miR-1178-3p/p21 axis and acts as a
prognostic factor of recurrence. Mol Cancer. 18:1332019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li M, Liu Y, Liu J, Li W, Li N, Xue D,
Zhang X and Wang P: Circ_0006332 promotes growth and progression of
bladder cancer by modulating MYBL2 expression via miR-143. Aging
(Albany NY). 11:10626–10643. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dai R, Jiang Q, Zhou Y, Lin R, Lin H,
Zhang Y, Zhang J and Gao X: Lnc-STYK1-2 regulates bladder cancer
cell proliferation, migration, and invasion by targeting
miR-146b-5p expression and AKT/STAT3/NF-kB signaling. Cancer Cell
Int. 21:4082021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He H, Yi L, Zhang B, Yan B, Xiao M, Ren J,
Zi D, Zhu L, Zhong Z, Zhao X, et al: USP24-GSDMB complex promotes
bladder cancer proliferation via activation of the STAT3 pathway.
Int J Biol Sci. 17:2417–2429. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abdollah F, Gandaglia G, Thuret R,
Schmitges J, Tian Z, Jeldres C, Passoni NM, Briganti A, Shariat SF,
Perrotte P, et al: Incidence, survival and mortality rates of
stage-specific bladder cancer in United States: A trend analysis.
Cancer Epidemiol. 37:219–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen M, Li J, Zhuang C and Cai Z:
Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of
bladder cancer. Oncotarget. 8:28176–28186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Wan B, Liu L, Zhou L and Zeng Q:
Circular RNA circMTO1 suppresses bladder cancer metastasis by
sponging miR-221 and inhibiting epithelial-to-mesenchymal
transition. Biochem Biophys Res Commun. 508:991–996. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Georgakopoulos-Soares I, Chartoumpekis DV,
Kyriazopoulou V and Zaravinos A: EMT factors and metabolic pathways
in cancer. Front Oncol. 10:4992020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ko JH, Yang MH, Baek SH, Nam D, Jung SH
and Ahn KS: Theacrine attenuates epithelial mesenchymal transition
in human breast cancer MDA-MB-231 cells. Phytother Res.
33:1934–1942. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang W, Lu Y, Wang F, Huang X and Yu Z:
Circular RNA circRNA_103809 accelerates bladder cancer progression
and enhances chemo-resistance by activation of miR-516a-5p/FBXL18
Axis. Cancer Manag Res. 12:7561–7568. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan C, Qu H, Xiong F, Tang Y, Tang T,
Zhang L, Mo Y, Li X, Guo C, Zhang S, et al: CircARHGAP12 promotes
nasopharyngeal carcinoma migration and invasion via ezrin-mediated
cytoskeletal remodeling. Cancer Lett. 496:41–56. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin X, Huang C, Chen Z, Wang H and Zeng Y:
CircRNA_100876 is upregulated in gastric cancer (GC) and promotes
the GC cells' growth, migration and invasion via miR-665/YAP1
signaling. Front Genet. 11:5462752020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang H, Zhao M, Zhao L, Li P, Duan Y and
Li G: CircRNA BIRC6 promotes non-small cell lung cancer cell
progression by sponging microRNA-145. Cell Oncol. 43:477–488. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L and Liu J: Research progress of
competing endogenous RNA. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
34:967–971. 2017.(In Chinese). PubMed/NCBI
|
|
35
|
Qian J, Garg A, Li F, Shen Q and Xiao K:
lncRNA LUNAR1 accelerates colorectal cancer progression by
targeting the miR-495-3p/MYCBP axis. Int J Oncol. 57:1157–1168.
2020.PubMed/NCBI
|
|
36
|
Zhao G, Zhang L, Qian D, Sun Y and Liu W:
miR-495-3p inhibits the cell proliferation, invasion and migration
of osteosarcoma by targeting C1q/TNF-related protein 3. OncoTargets
Ther. 12:6133–6143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mutalifu N, Du P, Zhang J, Akbar H, Yan B,
Alimu S, Tong L and Luan X: Circ_0000215 Increases the Expression
of CXCR2 and promoted the progression of glioma cells by sponging
miR-495-3p. Technol Cancer Res Treat. 19:1533033820957026.
2020.doi:10.1177/1533033820957026. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshida H, Oku M, Suzuki M and Mori K:
pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded
protein response activator pXBP1(S) in mammalian ER stress
response. J Cell Biol. 172:565–575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bagratuni T, Wu P, Gonzalez de Castro D,
Davenport EL, Dickens NJ, Walker BA, Boyd K, Johnson DC, Gregory W,
Morgan GJ and Davies FE: XBP1s levels are implicated in the biology
and outcome of myeloma mediating different clinical outcomes to
thalidomide-based treatments. Blood. 116:250–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Romero-Ramirez L, Cao H, Nelson D, Hammond
E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, et
al: XBP1 is essential for survival under hypoxic conditions and is
required for tumor growth. Cancer Res. 64:5943–5947. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xia T, Tong S, Fan K, Zhai W, Fang B, Wang
SH and Wang JJ: XBP1 induces MMP-9 expression to promote
proliferation and invasion in human esophageal squamous cell
carcinoma. Am J Cancer Res. 6:2031–2040. 2016.PubMed/NCBI
|
|
42
|
Li H, Chen X, Gao Y, Wu J, Zeng F and Song
F: XBP1 induces snail expression to promote epithelial-
to-mesenchymal transition and invasion of breast cancer cells. Cell
Signal. 27:82–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen W, Zhou J, Wu K, Huang J, Ding Y, Yun
EJ, Wang B, Ding C, Hernandez E, Santoyo J, et al: Targeting
XBP1-mediated β-catenin expression associated with bladder cancer
with newly synthetic oridonin analogues. Oncotarget. 7:56842–56854.
2016. View Article : Google Scholar : PubMed/NCBI
|
